Haleos Labs Limited

₹1,400As of Sun 8 Nov 2026, 12:00 UTC
NSE:HALEOSLABSHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 23.20%
Div yield 0.11%
ROE 8.06%
Biotechnology
Beta (5Y) 0.35
PE TTM 26.80
TSR TTM 18.62%
Mkt cap ₹4.234B
ROIC 5.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,745
24.61%
386.47%
Hold 0|10|2|1|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
24.51
27.31
30.20
32.29
17.48%
17.07%
25.49%
26.64%
Revenue₹M
212.3
215.3
216.9
217.8
13.56%
9.09%
9.72%
4.99%
Peers (US$45.23M)
Cap (US$)
PE
117.9M
19.70x
30.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.799
8.916
7.123
EBIT/Intx
0.045
0.262
0.240
Own earn%
(0.39)
(16.67)
5.12
Sh yield%
33.55
14.86
15.82
Owners
Insiders/Inst%
5.58
24.41
Short interest%
1.26
SBC / revenue%
4.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
11–18
$1 testx
—
Incr. ROIC%
7